Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 19/20 | 0.63 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3778528 | 0.93 | FAAH (0.70) | FAAHNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3771002 | 0.90 | FAAH (0.74) | FAAHSMN1; SMN2 | |
| SCHEMBL3770860 | 0.86 | FAAH (0.68) | FAAHNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3767431 | 0.85 | FAAH (0.60) | FAAHNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3772087 | 0.84 | FAAH (0.62) | FAAHNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3771933 | 0.83 | FAAH (0.63) | FAAHSMN1; SMN2 | |
| SCHEMBL3771939 | 0.83 | FAAH (0.63) | FAAHNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3270362 | 0.82 | FAAH (0.86) | FAAH | |
| SCHEMBL3774639 | 0.80 | FAAH (0.67) | FAAHNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3760999 | 0.79 | RAB9A (0.66) | FAAHNPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7851473-B2 | Amide compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-12-14 | — | — | US | disclosed |
| US-20080312226-A1 | Amide Compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-12-18 | — | — | US | disclosed |
| EP-1813606-A1 | AMIDE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2007-08-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312226-A1 | Amide Compound | FAAH, FAAH2, CNR2 | FAAH 1/4885NPC1 1078/4885RAB9A 1416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.